[Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
D000951:Antigens, Neoplasm / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis; D010051:Ovarian Neoplasms / Q000276:immunology*; D010455:Peptides / Q000032:analysis*; D019396:Tissue Polypeptide Antigen; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology*
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D009363:Neoplasm Proteins; D010455:Peptides; D019396:Tissue Polypeptide Antigen; C030193:immunosuppressive acidic protein